{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:13:38Z","timestamp":1788495218673,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ck0106745h0003"],"award-info":[{"award-number":["24ck0106745h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["26ck0106011h0002"],"award-info":[{"award-number":["26ck0106011h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.phro.2026.101060","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:09:36Z","timestamp":1785996576000},"page":"101060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical indicators for dose re-optimization in magnetic resonance-guided online adaptive radiotherapy for prostate cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"Masato","family":"Nishitani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sakasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tairo","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Nakaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Goka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2026.101060_bb0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13014-019-1308-y","article-title":"MR-guidance in clinical reality: current treatment challenges and future perspectives","volume":"14","author":"Corradini","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0010","article-title":"MR-guided radiotherapy: the perfect partner for immunotherapy?","volume":"10","author":"H\u00f6rner-Rieber","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clon.2018.08.001","article-title":"Adaptive radiotherapy enabled by MRI guidance","volume":"30","author":"Hunt","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.phro.2026.101060_bb0020","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology","volume":"109","author":"Glide-Hurst","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101060_bb0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2015.10.015","article-title":"Online magnetic resonance image guided adaptive radiation therapy: first clinical applications","volume":"94","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101060_bb0030","doi-asserted-by":"crossref","first-page":"N229","DOI":"10.1088\/0031-9155\/54\/12\/N01","article-title":"Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept","volume":"54","author":"Raaymakers","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2026.101060_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acm2.12529","article-title":"Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI","volume":"20","author":"Pathmanathan","year":"2019","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2026.101060_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/medicines5020032","article-title":"Dosimetric implications of computerised tomography-only versus magnetic resonance-fusion contouring in stereotactic body radiotherapy for prostate Cancer","volume":"5","author":"Henderson","year":"2018","journal-title":"Medicines"},{"key":"10.1016\/j.phro.2026.101060_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13014-020-01604-5","article-title":"Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow","volume":"15","author":"Mannerberg","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-8-58","article-title":"Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2022.06.002","article-title":"Identifying risk characteristics using failure mode and effect analysis for risk management in online magnetic resonance-guided adaptive radiation therapy","volume":"23","author":"Nishioka","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmp.2020.09.026","article-title":"Adaptive SBRT by 1.5 T MR-linac for prostate cancer: on the accuracy of dose delivery in view of the prolonged session time","volume":"80","author":"Ruggieri","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2026.101060_bb0065","article-title":"Automated planning for prostate stereotactic body radiation therapy on the 1.5 T MR-Linac","volume":"7","author":"Naccarato","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0070","article-title":"Volume change of the prostate during moderately hypo-fractionated radiotherapy assessed by artificial intelligence","volume":"34","author":"Christiansen","year":"2025","journal-title":"Phys Imaging Radiat Oncol."},{"key":"10.1016\/j.phro.2026.101060_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rpor.2019.02.005","article-title":"Investigation of the changes in the prostate, bladder, and rectal wall sizes during external beam radiotherapy","volume":"24","author":"Tanaka","year":"2019","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.phro.2026.101060_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1748-717X-9-22","article-title":"Change in prostate volume during extreme hypo-fractionation analysed with MRI","volume":"9","author":"Gunnlaugsson","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0085","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/j.clon.2022.03.022","article-title":"Prostate volume changes during extreme and moderately hypofractionated magnetic resonance image-guided radiotherapy","volume":"34","author":"Alexander","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac","volume":"151","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines(R) insights: prostate Cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.phro.2026.101060_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/20503121241287086","article-title":"Rectal toxicity of 3-dimensional conformal radiation therapy following hydrogel spacer (space OAR) injection for men with prostate cancer","volume":"12","author":"Kawaguchi","year":"2024","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.phro.2026.101060_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2022.02.002","article-title":"Seminal vesicle inter- and intra-fraction motion during radiotherapy for prostate cancer: a review","volume":"169","author":"Brand","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/acm2.12787","article-title":"Evaluation of a commercial DIR platform for contour propagation in prostate cancer patients treated with IMRT\/VMAT","volume":"21","author":"Hammers","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2026.101060_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/0284186X.2020.1821090","article-title":"Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy","volume":"60","author":"Nicosia","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0120","first-page":"35","article-title":"Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: initial clinical experiences and assessment of delivered doses compared to a C-arm linac","volume":"23","author":"Dunlop","year":"2020","journal-title":"Clin Transl Radiat Oncol."},{"key":"10.1016\/j.phro.2026.101060_bb0125","article-title":"Comparison of online adaptive and non-adaptive magnetic resonance image-guided radiation therapy in prostate cancer using dose accumulation","volume":"32","author":"Murr","year":"2024","journal-title":"Phys Imaging Radiat Oncol."},{"key":"10.1016\/j.phro.2026.101060_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110043","article-title":"Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity","volume":"190","author":"Nicosia","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101060_bb0135","article-title":"Ultrahypofractionated radiotherapy for localised prostate cancer: the impact of daily MRI-guided adaptive radiotherapy on delivered dose","volume":"53","author":"Alexander","year":"2025","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:29:45Z","timestamp":1788492585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631626001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S2405631626001600"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2026.101060","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical indicators for dose re-optimization in magnetic resonance-guided online adaptive radiotherapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2026.101060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101060"}}